JAGX stock: buy or sell?
September 20th, 2019
Jaguar Health, Inc., a commercial stage natural-products pharmaceuticals company, focuses on developing novel, sustainably derived gastrointestinal products for human prescription use and animals worldwide.
Should I buy JAGX stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Jaguar Health stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Jaguar Health stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 2 ratings published for JAGX stock in the last 30 days.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-12||LADENBURG THALM/SH SH||n/a||Buy|
JAGX stock analysis
Jaguar Health ended today at $1.44 and rose a remarkable 2.13%.
Shares of Jaguar Health ended today at $1.44 and rose a remarkable 2.13%.
Jaguar Health shares skyrocketed 8.27% this week, ending at $1.44. By mid August JAGX plummed a dreadful -38.74% in just one week.
Observing the weekly chart, price is in a simple uptrend, tested $1.05 level and now climbing back aiming its last top at $1.56. Since price and 20-weeks moving average lines crossed down early April, JAGX fell $-20.68 per share (-93.49%).
JAGX stock price history
JAGX stock went public on June 9th, 2016 with a price of $2,940.001. Since then, JAGX stock lost a -100.00%, with a yearly average of -33.30%.
1: Adjusted price after possible price splits or reverse-splits.
JAGX stock historical price chart
JAGX stock reached 52-week highs at $175.00, and all-time highs 2016-06-09 with a price of 3979.5.
JAGX stock price target is $10.00How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. Currently, only 1 price forecast for Jaguar Health stock was posted in the last 30 days:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-7-2||HC Wainwright||Set Price Target||n/a||$10.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareSince April, when Jaguar Health published its last earnings report, it . As soon as we get its posted EPS from the earnings report, we will extend this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Jaguar Health annual turnover gained a tiny 1.26% to $4.42 million USD from $4.36 marked in 2017. Nevertheless, its income margin (compared to sales) plunged to -727.92%, that is $-32.15 million.
|2015||$0.26 M||-||$-16.29 M-6305.2%||-|
|2016||$0.14 M||-45.23%||$-14.73 M-10410.9%||-9.56%|
|2017||$4.36 M||2,981.61%||$-21.97 M-503.7%||49.10%|
|2018||$4.42 M||1.26%||$-32.15 M-727.9%||46.33%|
Quarterly financial resultsJaguar Health posted $1.60 M in revenues for 2018-Q4, a 40.97% improvement compared to previous quarter. Reported quarter earnings marked $-12.65 million with a profit margin of -792.91%. Profit margin collapsed a -250.69% compared to previous quarter when profit margin was -542.22%. When comparing sales to same quarter last year, Jaguar Health sales marked a fine gain and appreciated a 3.49%. Looking back to recent quarterly results, Jaguar Health posted 3 negative quarters in a row.
|2017-Q1||$0.82 M||-||$-4.72 M-573.9%||-|
|2017-Q2||$0.90 M||9.01%||$-1.81 M-201.9%||-61.65%|
|2017-Q3||$1.10 M||22.72%||$4.76 M432.6%||-362.97%|
|2017-Q4||$1.54 M||40.16%||$-20.21 M-1310.4%||-524.54%|
|2018-Q1||$0.80 M||-47.84%||$-5.70 M-708.2%||-71.81%|
|2018-Q2||$0.88 M||9.88%||$-7.66 M-866.3%||34.42%|
|2018-Q3||$1.13 M||28.08%||$-6.14 M-542.2%||-19.84%|
|2018-Q4||$1.60 M||40.97%||$-12.65 M-792.9%||106.14%|
Jaguar Health ownershipWhen you are planning to buy a stock, it's always worth to overview its ownership structure.
Jaguar Health shares owned by insiders (that is, founders, CEO, CTO, main executives or other management staff) currently counts a 13.23% of all shares.
In case of Jaguar Health stock, 13.20% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for JAGX stock account 0.00%, no big difference from last month.
For a better context understanding, the following table shows ownership data compared to other related companies:
|Market cap||$8.7 M|
|Total shares||6.1 M|
|Float shares||5.5 M|
|- Institutional holdings (%)||13.2%|
|- Insider holdings (%)||13.2%|
|Shares in short selling||0.0%|
|Friday, September 20th, 2019|
|Day range||$1.31 - $1.45|
|Average true range||$0.13|
|50d mov avg||$1.56|
|100d mov avg||$5.37|
|200d mov avg||$11.71|
Jaguar Health performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We compared Jaguar Health against in the following table: